131 completed, 55 recruiting, 38 terminated, 38 unknown. 299 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 299 | Completed 131, Recruiting 55, Terminated 38, Unknown 38, Not yet recruiting 16, Withdrawn 13, Active not recruiting 7, Enrolling by invitation 1 |
Follow Bone Marrow Diseases: new trials by email Literature Review of Bone Marrow Diseases trials Research Report on Bone Marrow Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome Busulfan, Melphalan, Fludarabine - Myelodysplastic Syndromes, Graft Vs Host Disease | Not applicable | Not yet recruiting | Guenther Koehne | 62 | 2027-01-01 | 2026-10-13 |
| WELL-MPN: A Digital Lifestyle App for Patients With MPNs WELL-MPN Digital App - Myeloproliferative Neoplasms (MPNs) | Not applicable | Not yet recruiting | Brigham and Women's Hospital | 75 | 2027-01-01 | 2026-09-29 |
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia Bone marrow and blood samples, Bone marrow sample - Chronic Myelomonocytic Leukemia | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Nice | 120 | 2026-11-01 | 2026-10-01 |
| Peri-Transplant Gecacitinib in Patients With Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Peri-Transplant Gecacitinib - Myelofibrosis, Primary Myelofibrosis (PMF) | Not applicable | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 46 | 2026-11-01 | 2026-10-29 |
| Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative Standardized progress note - Polycythemia Vera | Not applicable | Recruiting | Massachusetts General Hospital | 32 | 2026-09-11 | 2026-11-13 |
| ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia Participants will take part in a 12-week exercise program that includes aerobic and resistance training, tailored to their individual fitness level and clinical condition. - Myeloproliferative Disease, Polycythemia Vera | Not applicable | Not yet recruiting | Carmen Fava | 25 | 2026-08-01 | 2026-04-09 |
| eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation eHealth Mindfulness-based Music Therapy (eMBMT), eHealth Mindfulness Meditation (eMM) - Stem Cell Transplantation, Myelodysplastic Syndromes | Not applicable | Recruiting | University of Miami | 165 | 2026-07-22 | 2026-11-20 |
| Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia G-CSF-Primed Peripheral Blood Stem Cell Graft, G-CSF-Primed Bone Marrow Plus Peripheral Blood Stem Cell Graft - Severe Aplastic Anemia (SAA) | Not applicable | Recruiting | Peking University People's Hospital | 180 | 2026-06-15 | 2026-09-16 |
| FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector Gene-modified autologous stem cells - Fanconi Anemia | Not applicable | Terminated | Shenzhen Geno-Immune Medical Institute | 10 | 2026-06-01 | 2026-11-03 |
| The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients MedMemos - Hematopoietic Cell Transplant | Not applicable | Recruiting | Nationwide Children's Hospital | 25 | 2026-05-01 | 2026-07-21 |
| Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin Goserelin Depot - Aplastic Anaemia (AA), Allogeneic Haematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 132 | 2026-05-01 | 2026-04-27 |
| Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS Bone marrow and blood sampling - Myelodysplastic Syndrome | Not applicable | Not yet recruiting | University Hospital, Grenoble | 120 | 2026-05-01 | 2026-03-06 |
| A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV Gecacitinib Hydrochloride Tablets;Pegylated interferon alfa-2b - Polycythemia Vera (PV) | Not applicable | Recruiting | Duan Minghui | 30 | 2026-04-02 | 2026-06-24 |
| A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients Allogeneic Hematopoietic Stem Cell Transplantation - Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome) | Not applicable | Recruiting | The First Affiliated Hospital of Soochow University | 30 | 2026-04-01 | 2026-04-15 |
| Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis Gecacitinib - aGVHD Prophylaxis | Not applicable | Not yet recruiting | Nanfang Hospital, Southern Medical University | 40 | 2026-03-01 | 2026-02-27 |
| Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia TBF regimen - Chronic Myelomonocytic Leukemia (CMML) | Not applicable | Recruiting | Peking University People's Hospital | 31 | 2026-02-13 | 2026-09-15 |
| Exercise Training in Patients With Myeloproliferative Neoplasms Exercise Training - Myeloproliferative Neoplasms (MPN) | Not applicable | Recruiting | Hannover Medical School | 80 | 2026-02-04 | 2026-08-14 |
| Identification of BCR::ABL1 Mutations by Digital PCR in CML Peripheral blood withdrawal for BCR::ABL1 mutations testing - Chronic Myeloid Leukemia (CML) | Not applicable | Not yet recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 150 | 2026-02-01 | 2025-09-05 |
| HID-HSCT Versus IST as First-line Treatment for SAA IST (ATG + CsA+TPORA), tranplantation - Aplastic Anaemia | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 116 | 2026-01-14 | 2026-01-13 |
Showing 20 of 299. Sign in to see all of them.
Myelodysplastic Syndromes (127) · Leukemia, Myeloid, Acute (103) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (82) · Leukemia (75) · Myeloproliferative Disorders (74) · Multiple Myeloma (69) · Lymphoma, Non-Hodgkin (66) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (62) · Hodgkin Disease (60) · Primary Myelofibrosis (60) · Leukemia, Lymphocytic, Chronic, B-Cell (58) · Lymphoma (48) · Leukemia, Myeloid, Chronic-Phase (45) · Anemia, Aplastic (44) · Burkitt Lymphoma (44)
Hemic and Lymphatic Diseases (299) · Hematologic Diseases (290) · Neoplasms (191) · Neoplasms by Histologic Type (186) · Leukemia, Myeloid (155) · Pathological Conditions, Signs and Symptoms (136) · Pathologic Processes (131) · Disease Attributes (124) · Immune System Diseases (124) · Chronic Disease (113) · Immunoproliferative Disorders (113) · Lymphatic Diseases (112) · Leukemia (108) · Lymphoproliferative Disorders (106)
Cyclophosphamide (32) · fludarabine phosphate (22) · Antilymphocyte Serum (19) · Busulfan (19) · Cyclosporine (17) · fludarabine (17) · Whole-Body Irradiation (16) · Peripheral Blood Stem Cell Transplantation (15) · Filgrastim (11) · Mycophenolic Acid (11) · Blood Specimen Collection (10) · Melphalan (10) · Methotrexate (9) · thymoglobulin (9) · Cytarabine (8)
Fred Hutchinson Cancer Center (12) · Masonic Cancer Center, University of Minnesota (11) · M.D. Anderson Cancer Center (10) · Institute of Hematology & Blood Diseases Hospital, China (8) · Memorial Sloan Kettering Cancer Center (6) · City of Hope Medical Center (5) · Peking University People's Hospital (5) · University Hospital, Angers (5) · University Hospital, Bordeaux (5) · University of California, San Francisco (5) · Assistance Publique - Hôpitaux de Paris (4) · Azienda Ospedaliero-Universitaria di Parma (4) · Dana-Farber Cancer Institute (4) · Hospices Civils de Lyon (4) · Institut Paoli-Calmettes (4)
United States (162) · France (43) · China (29) · Italy (13) · Canada (8) · Turkey (Türkiye) (5) · Denmark (4) · Germany (4) · Israel (4) · Australia (3) · Brazil (3) · South Korea (3) · United Kingdom (3) · Belgium (2) · Hong Kong (2)
Pamela Becker (3) · Robert Krance, MD (3) · Timothy Olson, MD, PhD (3) · Anna Pawlowska, MD (2) · Charles A. Linker, MD (2) · Claudio Brunstein, MD (2) · Damiano Rondelli, MD (2) · Daniel J. Weisdorf (2) · Depei Wu (2) · John Horan, MD (2) · Jorge Cortes, MD (2) · Kah Poh Loh (2) · Liping Jing, Doctor (2)
PMID 30504345, PMID 32499241, PMID 18379007, PMID 28423296, PMID 10626925, PMID 11591090, PMID 12590031, PMID 14520621, PMID 15466923, PMID 16609072, PMID 18215785, PMID 18363482, PMID 18515696, PMID 18698002, PMID 18997171, PMID 19008455, PMID 19474426, PMID 19546476, PMID 19690306, PMID 20712465, PMID 20965785, PMID 21233311, PMID 21393334, PMID 21454450, PMID 21477979, PMID 21494260, PMID 21714648, PMID 21715313, PMID 21719601, PMID 21788559, PMID 21976674, PMID 22343920, PMID 22504933, PMID 22609885, PMID 22740453, PMID 22762314, PMID 22826273, PMID 22874874, PMID 23065508, PMID 23358983, PMID 23524640, PMID 23838480, PMID 24559581, PMID 24996833, PMID 25234438, PMID 25380481, PMID 25656326, PMID 25800762, PMID 25800768, PMID 25822018
P30CA015704 (10), P30CA033572 (4), 4UL1TR000427-10 (2), P01CA018029 (2), P30CA014520 (2), P30CA016672 (2), P30CA072720 (2), K07CA136966 (1), K12CA167540 (1), P01HL036444 (1), P30CA006973 (1), P30CA022453 (1), P30CA060553 (1), R01AI058148 (1), R01CA107446 (1)